Policy paper

Drug strategy annual review: 2012 to 2013

This publication was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

The second annual review of the drug strategy, 'Delivering within a new landscape', updates progress on the 3 strands of the strategy since May 2012.

Documents

Drug strategy annual review: delivering within a new landscape

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Drug strategy 2010: evaluation framework

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

The drug strategy’s second annual review highlights the actions taken and the priorities for the year ahead on reducing demand, restricting supply and building recovery. Case studies are also provided.

Accompanying the review is the evaluation framework. The framework was developed to assess the drug strategy’s effectiveness and value for money. This document outlines the evaluation stages, the approach to evaluation and the next steps.